Why is Tenaya Therapeutics TNYA stock gaining attention recently Q4 2025 Better Than Expected DLO DLocal posts narrow Q4 2025 EPS beat shares gain 338 percent after earnings release Lam Research Corporation LRCX MATCH Act Policy Scrutiny Highlights China Exposure Risks Amid Contrasting Valuation and NearTerm Momentum